Cost Analysis of Cot-Side Screening Methods for Neonatal Hypoglycaemia

• DOI: 10.1159/000489080
• Publication Date: 2018-06-12T21:01:45Z
• Authors: Matthew J. Glasgow; Jane E. Harding; Richard Edlin
• Keywords: Blood Glucose; Infant, Newborn; Reproducibility of Results; Hypoglycemia; 3. Good health; 03 medical and health sciences; Neonatal Screening; 0302 clinical medicine; Point-of-Care Testing; Costs and Cost Analysis; Humans; Blood Chemical Analysis; New Zealand

<b><i>Background:</i></b> Babies at risk of neonatal hypoglycaemia are often screened using cot-side glucometers, but non-enzymatic glucometers inaccurate, potentially resulting in over-treatment and under-treatment, low values require laboratory confirmation. More accurate enzymatic available apparently higher costs. <b><i>Objective:</i></b> Our objective was to compare the cost screening for point-of-care glucometers. <b><i>Methods:</i></b> We used a decision tree model costs, including consumables staff time. Sensitivity analyses assessed impact time, probability that results confirmed via testing, false-positive false-negative rates blood glucose concentration threshold. <b><i>Results:</i></b> In primary analysis, an glucometer NZD 86.94 (USD 63.47) while 97.08 70.87) per baby. showed is saving with wide variations time irrespective level where ≥78% confirmed. Where may be less costly (e.g., rate exceeds 15%), instances will missed. Reducing threshold 1.94 mmol/L reduced incidence from 52 13%, 47.71 34.83). <b><i>Conclusions:</i></b> view their lower most circumstances greater accuracy, should routinely utilised hypoglycaemia.